# Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage

> **NCT04362527** · PHASE3 · COMPLETED · sponsor: **University Hospital, Angers** · enrollment: 370 (actual)

## Conditions studied

- Vasospasm

## Interventions

- **DRUG:** Milrinone 1 Mg/mL Solution for Injection
- **DRUG:** Saline solution for injection

## Key facts

- **NCT ID:** NCT04362527
- **Lead sponsor:** University Hospital, Angers
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-10
- **Primary completion:** 2025-10-11
- **Final completion:** 2026-01-12
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04362527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04362527, "Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04362527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*